Bartlett & Co Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bartlett & Co Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21K	Hold	594	–	–	﹤0.01%	812
2025 Q4	$18.5K	Hold	594	–	–	﹤0.01%	835
2025 Q3	$12K	Sell	594 -500	-46%	-$8.78K	﹤0.01%	896
2025 Q2	$18.3K	Hold	1,094	–	–	﹤0.01%	828
2025 Q1	$16.8K	Sell	1,094 -16	-1%	-$286	﹤0.01%	840
2024 Q4	$24.5K	Sell	1,110 -86	-7%	-$1.56K	﹤0.01%	780
2024 Q3	$21.6K	Buy	1,196 +86	+8%	+$1.5K	﹤0.01%	803
2024 Q2	$18K	Hold	1,110	–	–	﹤0.01%	829
2024 Q1	$15.7K	Buy	1,110 +16	+1%	+$202	﹤0.01%	854
2023 Q4	$11.5K	Buy	1,094 +594	+119%	+$5.55K	﹤0.01%	978
2023 Q3	$5.1K	Hold	500	–	–	﹤0.01%	989
2023 Q2	$3.77K	Hold	500	–	–	﹤0.01%	1021
2023 Q1	$4.42K	Hold	500	–	–	﹤0.01%	910
2022 Q4	$4.56K	Hold	500	–	–	﹤0.01%	935
2022 Q3	$4.04K	Hold	500	–	–	﹤0.01%	962
2022 Q2	$3.76K	Hold	500	–	–	﹤0.01%	1078
2022 Q1	$4.7K	Buy	+500	New	+$4.17K	﹤0.01%	925
2021 Q4	–	Sell	-500	Closed	-$4.87K	–	839
2021 Q3	$4.87K	Hold	500	–	–	﹤0.01%	767
2021 Q2	$4.95K	Hold	500	–	–	﹤0.01%	760
2021 Q1	$5.77K	Hold	500	–	–	﹤0.01%	778
2020 Q4	$4.83K	Hold	500	–	–	﹤0.01%	794
2020 Q3	$4.5K	Hold	500	–	–	﹤0.01%	744
2020 Q2	$6.17K	Sell	500 -65	-12%	-$735	﹤0.01%	724
2020 Q1	$5.07K	Hold	565	–	–	﹤0.01%	718
2019 Q4	$5.54K	Hold	565	–	–	﹤0.01%	757
2019 Q3	$3.89K	Hold	565	–	–	﹤0.01%	795
2019 Q2	$5.21K	Hold	565	–	–	﹤0.01%	627
2019 Q1	$8.86K	Hold	565	–	–	﹤0.01%	588
2018 Q4	$8.71K	Hold	565	–	–	﹤0.01%	590
2018 Q3	$12.2K	Hold	565	–	–	﹤0.01%	588
2018 Q2	$13.7K	Buy	565 +500	+769%	+$10.2K	﹤0.01%	570
2018 Q1	$1.11K	Buy	+65	New	+$1.27K	﹤0.01%	715

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bartlett & Co Wealth Management's TEVA Position: Q1 2026 in Review

Bartlett & Co Wealth Management held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 594 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Bartlett & Co Wealth Management first reported a position in TEVA in Q1 2018 and has held it in 32 quarters since. The position peaked at $24.5K in Q4 2024. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Bartlett & Co Wealth Management held 594 shares of Teva Pharmaceuticals worth $21K as of Q1 2026.
Bartlett & Co Wealth Management left its Teva Pharmaceuticals share count unchanged in Q1 2026.
Teva Pharmaceuticals made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #812 holding.
Bartlett & Co Wealth Management first reported a position in Teva Pharmaceuticals in Q1 2018 and has held it in 32 quarters since.
Bartlett & Co Wealth Management's Teva Pharmaceuticals position peaked at $24.5K in Q4 2024.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.